SciELO - Scientific Electronic Library Online

 
vol.40 issue2Profile of the physician undergoing education in radiology and diagnostic imagingMicroscopical analysis of fractionated cobalt-60 radiotherapy effects on mandibles of rats author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Radiologia Brasileira

Print version ISSN 0100-3984On-line version ISSN 1678-7099

Abstract

DIAS, Rodrigo Souza et al. Ruthenium-106 brachytherapy for uveal melanomas - preliminary results: a single institutional experience. Radiol Bras [online]. 2007, vol.40, n.2, pp.105-111. ISSN 0100-3984.  http://dx.doi.org/10.1590/S0100-39842007000200008.

OBJECTIVE: To analyze the early response of uveal melanomas in patients treated with ruthenium-106 brachytherapy. MATERIALS AND METHODS: In the period between April 2002 and July 2003, 20 patients diagnosed with uveal melanoma were submitted to ruthenium-106 brachytherapy. The calculated dose delivered at the apex of the tumor ranged between 55 Gy and 100 Gy. Patients with lesions greater than 5 mm were submitted to transpupillary thermotherapy concomitantly with ophthalmic plaque insertion. RESULTS: As regards the lesions site, 75% of the lesions were located in the choroid, 15% in the iris, and the remainder 10% in the ciliary body. In a median 19-month-follow-up, the progression-free survival for brachytherapy was 69%, and 87% for associated brachytherapy and transpupillary thermotherapy. A significant tumor height reduction was observed after treatment. No patient was submitted to enucleation. CONCLUSION: Our preliminary results show that ruthenium-106 brachytherapy is an appropriate method for conservative treatment of patients with uveal melanomas in terms of local management, ocular and visual acuity preservation with an acceptable complications incidence rate.

Keywords : Uveal melanoma; Ruthenium plaque therapy; Conservative therapy; Brachytherapy.

        · abstract in Portuguese     · text in English | Portuguese     · English ( pdf ) | Portuguese ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License